Concepts (276)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nanoparticles | 14 | 2024 | 318 | 4.250 |
Why?
|
| beta-Glucans | 5 | 2023 | 10 | 3.590 |
Why?
|
| Ionic Liquids | 4 | 2023 | 16 | 3.170 |
Why?
|
| Drug Delivery Systems | 13 | 2024 | 202 | 3.150 |
Why?
|
| Graphite | 9 | 2023 | 51 | 3.040 |
Why?
|
| Antineoplastic Agents | 6 | 2023 | 803 | 2.170 |
Why?
|
| Neoplasms | 7 | 2023 | 1103 | 2.010 |
Why?
|
| Quantum Dots | 10 | 2017 | 30 | 1.970 |
Why?
|
| Excipients | 2 | 2024 | 22 | 1.810 |
Why?
|
| Liposomes | 2 | 2024 | 118 | 1.800 |
Why?
|
| Melanoma | 2 | 2023 | 96 | 1.610 |
Why?
|
| Stomach Neoplasms | 2 | 2023 | 195 | 1.580 |
Why?
|
| Skin | 4 | 2024 | 174 | 1.500 |
Why?
|
| Nanostructures | 5 | 2023 | 134 | 1.490 |
Why?
|
| Diagnostic Imaging | 5 | 2014 | 53 | 1.460 |
Why?
|
| Exosomes | 2 | 2022 | 101 | 1.410 |
Why?
|
| Administration, Cutaneous | 3 | 2024 | 43 | 1.400 |
Why?
|
| Pulmonary Fibrosis | 3 | 2024 | 31 | 1.380 |
Why?
|
| Fibrosis | 4 | 2024 | 159 | 1.370 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 3 | 2024 | 152 | 1.320 |
Why?
|
| Mice | 22 | 2024 | 5913 | 1.290 |
Why?
|
| Animals | 29 | 2024 | 15081 | 1.230 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 2 | 2024 | 28 | 1.170 |
Why?
|
| Apoptosis | 4 | 2024 | 1398 | 1.150 |
Why?
|
| Sulfonamides | 2 | 2024 | 80 | 1.140 |
Why?
|
| Rheology | 3 | 2024 | 25 | 1.130 |
Why?
|
| Phototherapy | 4 | 2023 | 19 | 1.120 |
Why?
|
| Mice, Inbred C57BL | 4 | 2024 | 1609 | 1.110 |
Why?
|
| Photochemotherapy | 3 | 2023 | 39 | 1.110 |
Why?
|
| Biocompatible Materials | 3 | 2023 | 76 | 1.000 |
Why?
|
| Biosensing Techniques | 3 | 2023 | 86 | 0.970 |
Why?
|
| Skin Absorption | 1 | 2024 | 15 | 0.970 |
Why?
|
| Obesity | 3 | 2022 | 1067 | 0.970 |
Why?
|
| Drug Carriers | 7 | 2023 | 125 | 0.970 |
Why?
|
| Lidocaine | 1 | 2024 | 17 | 0.960 |
Why?
|
| Emulsions | 1 | 2024 | 33 | 0.960 |
Why?
|
| Gels | 1 | 2024 | 42 | 0.960 |
Why?
|
| Petroleum | 1 | 2024 | 11 | 0.960 |
Why?
|
| Cadherins | 1 | 2024 | 90 | 0.920 |
Why?
|
| Biomimetic Materials | 1 | 2023 | 23 | 0.890 |
Why?
|
| Angiotensins | 1 | 2022 | 8 | 0.880 |
Why?
|
| Humans | 39 | 2024 | 37093 | 0.850 |
Why?
|
| Fatty Acids | 1 | 2023 | 127 | 0.830 |
Why?
|
| Carbon | 5 | 2023 | 105 | 0.820 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2021 | 643 | 0.820 |
Why?
|
| Gene Transfer Techniques | 3 | 2022 | 47 | 0.800 |
Why?
|
| Iron | 1 | 2023 | 225 | 0.790 |
Why?
|
| Leptin | 1 | 2022 | 118 | 0.780 |
Why?
|
| Transforming Growth Factor beta | 1 | 2022 | 197 | 0.770 |
Why?
|
| Biological Products | 1 | 2022 | 71 | 0.760 |
Why?
|
| Skin Neoplasms | 1 | 2022 | 159 | 0.740 |
Why?
|
| Bleomycin | 3 | 2024 | 20 | 0.720 |
Why?
|
| Pharmaceutical Preparations | 1 | 2021 | 75 | 0.710 |
Why?
|
| Boron Compounds | 2 | 2018 | 16 | 0.710 |
Why?
|
| Administration, Oral | 7 | 2022 | 224 | 0.680 |
Why?
|
| Lung Neoplasms | 1 | 2023 | 358 | 0.670 |
Why?
|
| Dietary Fats | 1 | 2019 | 119 | 0.670 |
Why?
|
| Liver Neoplasms | 1 | 2021 | 190 | 0.650 |
Why?
|
| Polyethylene Glycols | 5 | 2023 | 84 | 0.630 |
Why?
|
| Nanotechnology | 3 | 2023 | 153 | 0.630 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2017 | 10 | 0.610 |
Why?
|
| Luminescence | 2 | 2014 | 24 | 0.610 |
Why?
|
| DNA | 2 | 2018 | 574 | 0.600 |
Why?
|
| RNA, Small Interfering | 3 | 2023 | 409 | 0.580 |
Why?
|
| Spectroscopy, Near-Infrared | 3 | 2013 | 30 | 0.560 |
Why?
|
| Cell Line, Tumor | 9 | 2023 | 2231 | 0.550 |
Why?
|
| Micelles | 3 | 2014 | 32 | 0.500 |
Why?
|
| Water | 3 | 2024 | 296 | 0.470 |
Why?
|
| Gastrointestinal Tract | 3 | 2023 | 61 | 0.440 |
Why?
|
| Lung | 3 | 2024 | 446 | 0.420 |
Why?
|
| Heparin | 3 | 2017 | 35 | 0.390 |
Why?
|
| Doxorubicin | 3 | 2022 | 84 | 0.360 |
Why?
|
| Infrared Rays | 1 | 2010 | 18 | 0.360 |
Why?
|
| Polymers | 3 | 2018 | 121 | 0.360 |
Why?
|
| Adipose Tissue | 2 | 2021 | 177 | 0.340 |
Why?
|
| Erythrocytes | 2 | 2018 | 111 | 0.280 |
Why?
|
| Surface Properties | 3 | 2016 | 130 | 0.270 |
Why?
|
| Hydrogels | 2 | 2024 | 37 | 0.270 |
Why?
|
| Taurocholic Acid | 2 | 2017 | 7 | 0.270 |
Why?
|
| Light | 3 | 2023 | 187 | 0.270 |
Why?
|
| Petrolatum | 1 | 2024 | 2 | 0.240 |
Why?
|
| Administration, Topical | 1 | 2024 | 40 | 0.240 |
Why?
|
| Viscosity | 1 | 2024 | 38 | 0.240 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2024 | 12 | 0.240 |
Why?
|
| Aniline Compounds | 1 | 2024 | 23 | 0.240 |
Why?
|
| Photosensitizing Agents | 2 | 2015 | 49 | 0.240 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2024 | 71 | 0.240 |
Why?
|
| Male | 6 | 2024 | 20025 | 0.230 |
Why?
|
| Drug Stability | 1 | 2024 | 116 | 0.230 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2019 | 1618 | 0.230 |
Why?
|
| Swine | 1 | 2024 | 184 | 0.230 |
Why?
|
| Ketones | 1 | 2023 | 17 | 0.230 |
Why?
|
| Cobalt | 1 | 2023 | 26 | 0.230 |
Why?
|
| Rats | 2 | 2022 | 3483 | 0.230 |
Why?
|
| Antibodies, Neutralizing | 1 | 2024 | 109 | 0.230 |
Why?
|
| Fluorouracil | 1 | 2023 | 34 | 0.230 |
Why?
|
| Docosahexaenoic Acids | 1 | 2023 | 18 | 0.230 |
Why?
|
| Immunotherapy | 1 | 2024 | 95 | 0.220 |
Why?
|
| Glycerophospholipids | 1 | 2022 | 3 | 0.220 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2022 | 18 | 0.220 |
Why?
|
| Cell Line | 2 | 2017 | 1354 | 0.220 |
Why?
|
| Microscopy, Confocal | 2 | 2016 | 218 | 0.220 |
Why?
|
| Cell Survival | 7 | 2017 | 864 | 0.220 |
Why?
|
| Caprylates | 1 | 2022 | 11 | 0.210 |
Why?
|
| Fibroblasts | 1 | 2024 | 272 | 0.210 |
Why?
|
| Bile Acids and Salts | 1 | 2022 | 33 | 0.210 |
Why?
|
| Intestinal Absorption | 2 | 2019 | 20 | 0.200 |
Why?
|
| RNA Interference | 1 | 2023 | 243 | 0.200 |
Why?
|
| Choline | 1 | 2022 | 59 | 0.200 |
Why?
|
| Collagen | 1 | 2022 | 172 | 0.200 |
Why?
|
| Colon | 1 | 2022 | 103 | 0.200 |
Why?
|
| Hydrogen Bonding | 1 | 2021 | 132 | 0.200 |
Why?
|
| Hydroxychloroquine | 1 | 2021 | 15 | 0.190 |
Why?
|
| Respiration, Artificial | 1 | 2021 | 39 | 0.190 |
Why?
|
| Cell Communication | 1 | 2022 | 97 | 0.190 |
Why?
|
| Electrochemical Techniques | 1 | 2020 | 22 | 0.190 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2022 | 222 | 0.190 |
Why?
|
| Fullerenes | 1 | 2021 | 31 | 0.190 |
Why?
|
| Electricity | 1 | 2020 | 9 | 0.190 |
Why?
|
| Cell Cycle Proteins | 1 | 2022 | 229 | 0.180 |
Why?
|
| Ultrasonography | 1 | 2020 | 112 | 0.180 |
Why?
|
| Cytokines | 1 | 2023 | 602 | 0.180 |
Why?
|
| Nanotubes, Carbon | 1 | 2021 | 79 | 0.180 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2021 | 103 | 0.170 |
Why?
|
| Antiviral Agents | 1 | 2021 | 157 | 0.170 |
Why?
|
| Tissue Distribution | 3 | 2017 | 207 | 0.170 |
Why?
|
| Particle Size | 4 | 2017 | 215 | 0.170 |
Why?
|
| Liver | 1 | 2022 | 479 | 0.170 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 935 | 0.170 |
Why?
|
| Hyaluronic Acid | 2 | 2017 | 33 | 0.170 |
Why?
|
| Tissue Engineering | 2 | 2021 | 60 | 0.160 |
Why?
|
| Eating | 1 | 2020 | 166 | 0.160 |
Why?
|
| Peptides | 1 | 2021 | 320 | 0.160 |
Why?
|
| Polylysine | 1 | 2018 | 8 | 0.160 |
Why?
|
| Quality of Life | 1 | 2022 | 481 | 0.160 |
Why?
|
| Mice, Nude | 3 | 2013 | 337 | 0.150 |
Why?
|
| Blood Coagulation | 1 | 2018 | 23 | 0.150 |
Why?
|
| Metal Nanoparticles | 1 | 2020 | 183 | 0.150 |
Why?
|
| Transcription Factors | 1 | 2023 | 681 | 0.150 |
Why?
|
| Histamine | 1 | 2017 | 18 | 0.150 |
Why?
|
| Anti-Bacterial Agents | 1 | 2021 | 352 | 0.150 |
Why?
|
| Rats, Zucker | 1 | 2017 | 23 | 0.150 |
Why?
|
| Immune Tolerance | 1 | 2017 | 65 | 0.150 |
Why?
|
| Leukemia | 1 | 2017 | 56 | 0.150 |
Why?
|
| Antigens, Viral | 1 | 2017 | 43 | 0.150 |
Why?
|
| Plasmids | 1 | 2018 | 246 | 0.140 |
Why?
|
| Oligopeptides | 1 | 2017 | 102 | 0.140 |
Why?
|
| Heparin, Low-Molecular-Weight | 2 | 2013 | 8 | 0.140 |
Why?
|
| Methacrylates | 1 | 2016 | 5 | 0.140 |
Why?
|
| Hemoglobins | 1 | 2016 | 107 | 0.140 |
Why?
|
| Intestinal Mucosa | 1 | 2017 | 122 | 0.140 |
Why?
|
| Cross-Linking Reagents | 1 | 2016 | 51 | 0.140 |
Why?
|
| Deoxycholic Acid | 2 | 2012 | 10 | 0.130 |
Why?
|
| Chitosan | 1 | 2016 | 36 | 0.130 |
Why?
|
| Neoplasms, Experimental | 1 | 2015 | 37 | 0.130 |
Why?
|
| Nanocapsules | 1 | 2015 | 17 | 0.130 |
Why?
|
| Chlorophyll | 1 | 2015 | 22 | 0.130 |
Why?
|
| Cadmium Compounds | 2 | 2014 | 7 | 0.130 |
Why?
|
| Ferric Compounds | 1 | 2015 | 51 | 0.120 |
Why?
|
| Polyethylene Terephthalates | 1 | 2014 | 2 | 0.120 |
Why?
|
| Selenium Compounds | 2 | 2014 | 11 | 0.120 |
Why?
|
| Tin Compounds | 1 | 2014 | 3 | 0.120 |
Why?
|
| Polytetrafluoroethylene | 1 | 2014 | 6 | 0.120 |
Why?
|
| Solar Energy | 1 | 2014 | 9 | 0.120 |
Why?
|
| Electrodes | 1 | 2014 | 45 | 0.120 |
Why?
|
| Enzymes | 1 | 2014 | 32 | 0.120 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 1371 | 0.120 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2014 | 98 | 0.120 |
Why?
|
| Fluorescence | 2 | 2015 | 121 | 0.120 |
Why?
|
| Antibodies | 1 | 2014 | 141 | 0.120 |
Why?
|
| Biomedical Technology | 1 | 2013 | 8 | 0.120 |
Why?
|
| Luminescent Proteins | 1 | 2014 | 77 | 0.120 |
Why?
|
| Biomedical Engineering | 1 | 2013 | 5 | 0.110 |
Why?
|
| Bivalvia | 1 | 2013 | 21 | 0.110 |
Why?
|
| Photochemistry | 1 | 2013 | 63 | 0.110 |
Why?
|
| Diet | 1 | 2020 | 801 | 0.110 |
Why?
|
| Toxicity Tests | 1 | 2013 | 43 | 0.110 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2013 | 62 | 0.110 |
Why?
|
| Solubility | 1 | 2013 | 118 | 0.110 |
Why?
|
| Transplantation, Heterologous | 1 | 2013 | 90 | 0.110 |
Why?
|
| Mitochondria | 1 | 2017 | 487 | 0.110 |
Why?
|
| Taxoids | 1 | 2013 | 37 | 0.110 |
Why?
|
| Breast Neoplasms | 1 | 2024 | 1502 | 0.110 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2013 | 259 | 0.110 |
Why?
|
| Dogs | 1 | 2013 | 149 | 0.110 |
Why?
|
| Gold | 1 | 2014 | 136 | 0.110 |
Why?
|
| Indoles | 1 | 2013 | 158 | 0.100 |
Why?
|
| Female | 7 | 2024 | 20969 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2015 | 481 | 0.100 |
Why?
|
| Anticoagulants | 1 | 2012 | 102 | 0.100 |
Why?
|
| Tellurium | 1 | 2010 | 5 | 0.100 |
Why?
|
| Nanospheres | 1 | 2010 | 7 | 0.100 |
Why?
|
| Whole Body Imaging | 1 | 2010 | 25 | 0.090 |
Why?
|
| Polyglycolic Acid | 1 | 2010 | 37 | 0.090 |
Why?
|
| Polyesters | 1 | 2010 | 25 | 0.090 |
Why?
|
| Caco-2 Cells | 3 | 2017 | 52 | 0.090 |
Why?
|
| Lactic Acid | 1 | 2010 | 95 | 0.090 |
Why?
|
| Time Factors | 1 | 2013 | 1742 | 0.080 |
Why?
|
| Cell Proliferation | 2 | 2014 | 1198 | 0.080 |
Why?
|
| Antibodies, Monoclonal | 1 | 2010 | 290 | 0.080 |
Why?
|
| Delayed-Action Preparations | 2 | 2020 | 60 | 0.080 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 2016 | 142 | 0.070 |
Why?
|
| Contrast Media | 2 | 2015 | 92 | 0.060 |
Why?
|
| Treatment Outcome | 2 | 2021 | 1369 | 0.060 |
Why?
|
| Ethers | 1 | 2023 | 20 | 0.060 |
Why?
|
| Serum Response Factor | 1 | 2023 | 10 | 0.060 |
Why?
|
| Genes, Switch | 1 | 2022 | 3 | 0.060 |
Why?
|
| Reactive Oxygen Species | 2 | 2017 | 461 | 0.060 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2022 | 10 | 0.050 |
Why?
|
| rho-Associated Kinases | 1 | 2023 | 31 | 0.050 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2022 | 122 | 0.050 |
Why?
|
| Immunization, Passive | 1 | 2021 | 19 | 0.050 |
Why?
|
| Latin America | 1 | 2021 | 45 | 0.050 |
Why?
|
| Onions | 1 | 2021 | 7 | 0.050 |
Why?
|
| Asia | 1 | 2021 | 75 | 0.050 |
Why?
|
| Europe | 1 | 2021 | 101 | 0.050 |
Why?
|
| Cesarean Section | 1 | 2021 | 55 | 0.050 |
Why?
|
| Iontophoresis | 1 | 2020 | 10 | 0.050 |
Why?
|
| Equipment Design | 1 | 2020 | 124 | 0.050 |
Why?
|
| Electroporation | 1 | 2020 | 18 | 0.050 |
Why?
|
| Pregnancy Outcome | 1 | 2021 | 87 | 0.050 |
Why?
|
| Disease Progression | 1 | 2022 | 601 | 0.050 |
Why?
|
| Length of Stay | 1 | 2021 | 185 | 0.040 |
Why?
|
| Premature Birth | 1 | 2021 | 75 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2023 | 587 | 0.040 |
Why?
|
| Blood-Brain Barrier | 1 | 2020 | 162 | 0.040 |
Why?
|
| Hemorheology | 1 | 2018 | 8 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2021 | 894 | 0.040 |
Why?
|
| Dihydroxyphenylalanine | 1 | 2017 | 8 | 0.040 |
Why?
|
| K562 Cells | 1 | 2017 | 32 | 0.040 |
Why?
|
| Vaccines, Conjugate | 1 | 2017 | 7 | 0.040 |
Why?
|
| Molecular Conformation | 1 | 2017 | 152 | 0.040 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2017 | 19 | 0.040 |
Why?
|
| Biological Transport | 1 | 2017 | 185 | 0.040 |
Why?
|
| Hep G2 Cells | 1 | 2017 | 51 | 0.040 |
Why?
|
| Erythrocyte Deformability | 1 | 2016 | 1 | 0.040 |
Why?
|
| Hela Cells | 1 | 2018 | 366 | 0.040 |
Why?
|
| Phase Transition | 1 | 2016 | 9 | 0.030 |
Why?
|
| Chondrocytes | 1 | 2016 | 16 | 0.030 |
Why?
|
| Vaccines | 1 | 2017 | 55 | 0.030 |
Why?
|
| Muramidase | 1 | 2016 | 22 | 0.030 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2016 | 68 | 0.030 |
Why?
|
| Pregnancy | 1 | 2021 | 1549 | 0.030 |
Why?
|
| Polyethyleneimine | 1 | 2015 | 2 | 0.030 |
Why?
|
| Rabbits | 1 | 2016 | 283 | 0.030 |
Why?
|
| KB Cells | 1 | 2015 | 7 | 0.030 |
Why?
|
| Ultraviolet Rays | 1 | 2016 | 117 | 0.030 |
Why?
|
| Diffusion | 1 | 2015 | 50 | 0.030 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2015 | 44 | 0.030 |
Why?
|
| Chickens | 1 | 2016 | 133 | 0.030 |
Why?
|
| Temperature | 1 | 2016 | 286 | 0.030 |
Why?
|
| Adenosine | 1 | 2014 | 59 | 0.030 |
Why?
|
| Zinc Compounds | 1 | 2014 | 12 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2016 | 492 | 0.030 |
Why?
|
| Cell Death | 1 | 2015 | 267 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2017 | 808 | 0.030 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2014 | 113 | 0.030 |
Why?
|
| Sulfides | 1 | 2014 | 62 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 2014 | 190 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2013 | 77 | 0.030 |
Why?
|
| Glucose | 1 | 2014 | 230 | 0.030 |
Why?
|
| Mice, Hairless | 1 | 2012 | 7 | 0.030 |
Why?
|
| Ileum | 1 | 2012 | 15 | 0.030 |
Why?
|
| Biochemistry | 1 | 2012 | 13 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2014 | 409 | 0.030 |
Why?
|
| Scattering, Radiation | 1 | 2012 | 47 | 0.030 |
Why?
|
| Intestines | 1 | 2012 | 64 | 0.030 |
Why?
|
| Cadmium | 1 | 2012 | 58 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2014 | 661 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2012 | 146 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2012 | 364 | 0.020 |
Why?
|
| United States | 1 | 2021 | 4223 | 0.020 |
Why?
|
| Luminescent Measurements | 1 | 2010 | 26 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 1039 | 0.020 |
Why?
|
| Young Adult | 1 | 2021 | 4268 | 0.020 |
Why?
|
| Adult | 1 | 2021 | 11712 | 0.020 |
Why?
|